Deerfield Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-19,866
| Closed | -$671K | – | 149 |
|
|
2021
Q1 | $671K | Sell |
19,866
-124,601
| -86% | -$4.21M | 0.01% | 131 |
|
|
2020
Q4 | $12.7M | Buy |
144,467
+15,054
| +12% | +$1.33M | 0.25% | 93 |
|
|
2020
Q3 | $10.5M | Buy |
129,413
+23,413
| +22% | +$1.9M | 0.26% | 81 |
|
|
2020
Q2 | $11.7M | Sell |
106,000
-19,000
| -15% | -$2.1M | 0.34% | 72 |
|
|
2020
Q1 | $8.02M | Buy |
+125,000
| New | +$8.02M | 0.25% | 74 |
|